Page last updated: 2024-08-18

allylamine and Glucose Intolerance

allylamine has been researched along with Glucose Intolerance in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jialal, I; Sheely, D1
Kahn, SE; Marcovina, SM; Marina, AL; Montgomery, BK; Utzschneider, KM; Wright, LA1
Elisaf, MS; Florentin, M; Kei, AA; Kostapanos, MS; Liamis, G; Liberopoulos, EN; Rizos, CV1

Trials

2 trial(s) available for allylamine and Glucose Intolerance

ArticleYear
Colesevelam improves oral but not intravenous glucose tolerance by a mechanism independent of insulin sensitivity and β-cell function.
    Diabetes care, 2012, Volume: 35, Issue:5

    Topics: Adult; Aged; Allylamine; Blood Glucose; Colesevelam Hydrochloride; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged

2012
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.
    Metabolic syndrome and related disorders, 2013, Volume: 11, Issue:3

    Topics: Aged; Allylamine; Anticholesteremic Agents; Biomarkers; Blood Glucose; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Prediabetic State; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2013

Other Studies

1 other study(ies) available for allylamine and Glucose Intolerance

ArticleYear
Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk.
    Metabolic syndrome and related disorders, 2013, Volume: 11, Issue:3

    Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2013